Table: begin end state 1 27 cytoplasmic 28 49 transmembrane 50 54 non-cytoplasmic 55 72 transmembrane 73 77 cytoplasmic 78 97 transmembrane 98 102 non-cytoplasmic 103 123 transmembrane 124 131 cytoplasmic 132 153 transmembrane 154 175 non-cytoplasmic 176 200 transmembrane 201 210 cytoplasmic 211 234 transmembrane 235 252 non-cytoplasmic 253 276 transmembrane 277 323 cytoplasmic 324 345 transmembrane 346 348 non-cytoplasmic 349 370 transmembrane 371 386 cytoplasmic 387 416 transmembrane 417 452 non-cytoplasmic 453 522 cytoplasmic
Input: >Pf6N2E2_4131 MAIPTRHSLFPFLSWLPRQTRASVGRDLVVGLSGAILALPQSIAYALIAGLPPEYGLYAA IVPVLIACLWGSSWHLICGPTAAISIVLYATVSPLAVPASQDYITLILLLTVLAGIFQWL LGLLRFGALVNFVSHSVVLGFTLGAAVVIALGQLPNLLGLDLPNEATALRGLLMLVSHIG AVDKPSLLLGLGTLVLGVVLKRLLPRWPSLLITLVISSLVVWLWPAMFGHVALVSAFAGR LPPFTPLPLDLELILRLLPGAVAVGMLGLVTSLSIARSLSVRSGQLLDANQEVRAQGLSN IVGGFFSGSLSAGSFTRSGLSYEAGACSPLAGVFSALWVALFAVAGANLIAHIPIPAMAG SILLIAWGLVDHRGIRALYRVSRAEFVVMGLTCLATLLLELQTAIYAGVLASLFFYLKRT SQPRVQHFREGEAEILRVGGSIFFGASHYLQARLQRLQAQRVVIDAQQINFIDYSGVEML HQEARRLRSQGRSLTLRMARPQVVEELLKLEGAEHCPILFED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server